DE602007011476D1 - Diagnostik-biomolekül(e) - Google Patents

Diagnostik-biomolekül(e)

Info

Publication number
DE602007011476D1
DE602007011476D1 DE602007011476T DE602007011476T DE602007011476D1 DE 602007011476 D1 DE602007011476 D1 DE 602007011476D1 DE 602007011476 T DE602007011476 T DE 602007011476T DE 602007011476 T DE602007011476 T DE 602007011476T DE 602007011476 D1 DE602007011476 D1 DE 602007011476D1
Authority
DE
Germany
Prior art keywords
biomolecule
diagnostics
quantitating
quantification
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007011476T
Other languages
English (en)
Inventor
Mahesh Arjandas Choolani
Khan Khalil Razvi B Jabarullah
Loganath Annamalai
Arijit Biswas
Changqing Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National University of Singapore
Original Assignee
National University of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University of Singapore filed Critical National University of Singapore
Publication of DE602007011476D1 publication Critical patent/DE602007011476D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DE602007011476T 2006-09-05 2007-08-20 Diagnostik-biomolekül(e) Active DE602007011476D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG200605961-2A SG140505A1 (en) 2006-09-05 2006-09-05 Diagnostic biomolecule(s)
PCT/SG2007/000264 WO2008030186A1 (en) 2006-09-05 2007-08-20 Diagnostic biomolecule(s)

Publications (1)

Publication Number Publication Date
DE602007011476D1 true DE602007011476D1 (de) 2011-02-03

Family

ID=39157516

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007011476T Active DE602007011476D1 (de) 2006-09-05 2007-08-20 Diagnostik-biomolekül(e)

Country Status (10)

Country Link
US (1) US8551712B2 (de)
EP (1) EP2074427B1 (de)
CN (1) CN101589308B (de)
AT (1) ATE492815T1 (de)
AU (1) AU2007293693C1 (de)
DE (1) DE602007011476D1 (de)
ES (1) ES2362121T3 (de)
MY (1) MY145455A (de)
SG (1) SG140505A1 (de)
WO (1) WO2008030186A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021509D0 (en) * 2010-12-20 2011-02-02 Reactivlab Ltd Assay method
US9476095B2 (en) 2011-04-15 2016-10-25 The Johns Hopkins University Safe sequencing system
US8697368B2 (en) * 2011-06-29 2014-04-15 Paichai University-Academic Cooperation Foundation Diagnostic marker for lung cancer comprising HPαR as active ingredient
EP3447495B2 (de) 2012-10-29 2024-03-13 The Johns Hopkins University Papanicolaou-test für ovarial- und endometriumkarzinome
ES2805852T3 (es) * 2013-12-05 2021-02-15 Univ Leipzig Procedimiento y medio para el diagnóstico no invasivo de diabetes mellitus tipo II
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
CN109313193B (zh) * 2016-05-27 2022-09-23 富士胶片株式会社 消化道癌的判定方法
TWI709188B (zh) 2018-09-27 2020-11-01 財團法人工業技術研究院 基於機率融合的分類器、分類方法及分類系統

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723773D0 (en) * 1997-11-12 1998-01-07 Univ Glasgow Haptoglobin assay
US7112408B2 (en) * 2001-06-08 2006-09-26 The Brigham And Women's Hospital, Inc. Detection of ovarian cancer based upon alpha-haptoglobin levels
US20070053896A1 (en) * 2003-09-05 2007-03-08 Royal Women's Hospital Diagnostic marker for ovarian cancer
CA2611173C (en) * 2005-06-24 2019-11-12 Ciphergen Biosystems, Inc. Biomarkers for ovarian cancer

Also Published As

Publication number Publication date
EP2074427A4 (de) 2010-01-27
AU2007293693A1 (en) 2008-03-13
WO2008030186A8 (en) 2009-07-23
EP2074427B1 (de) 2010-12-22
AU2007293693B2 (en) 2013-08-01
CN101589308A (zh) 2009-11-25
US8551712B2 (en) 2013-10-08
WO2008030186A1 (en) 2008-03-13
SG140505A1 (en) 2008-03-28
EP2074427A1 (de) 2009-07-01
US20100158916A1 (en) 2010-06-24
ATE492815T1 (de) 2011-01-15
MY145455A (en) 2012-02-15
ES2362121T3 (es) 2011-06-28
AU2007293693C1 (en) 2013-11-14
CN101589308B (zh) 2013-11-13

Similar Documents

Publication Publication Date Title
DE602007011476D1 (de) Diagnostik-biomolekül(e)
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
ATE529752T1 (de) Antikörperquantifizierung
NO20083820L (no) Deteksjon av kreft ved forhoyede nivaer av BCL-2
DK1889059T3 (da) Fremgangsmåde til forbedret immunoassay
MY157955A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
ATE419534T1 (de) Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit
ATE504002T1 (de) Erkennung und vorhersage von frühgeburten
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
GB2437545B (en) Dextrin-containing reagents for detecting and quantifying proteins
WO2006102526A3 (en) Identification of biomarkers by serum protein profiling
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
WO2006096697A3 (en) Methods for determining the bivalency of protein and antibody therapeutics
ATE538217T1 (de) Erkennung von ektopischen schwangerschaften
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
SE0602683L (sv) Diagnostisk metod
CY1117709T1 (el) Αναλυτικη μεθοδος για μορια fab και fab'
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
DE602005014659D1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
DE602005026587D1 (de) Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
PT1991875E (pt) Teste para a detecção de priões patológicos
ATE529745T1 (de) Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation
GB0802456D0 (en) Diagnostic method